BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 27696393)

  • 1. Increased protoporphyrin IX accumulation does not improve the effect of photodynamic therapy for actinic keratosis: a randomized controlled trial.
    Nissen CV; Heerfordt IM; Wiegell SR; Mikkelsen CS; Wulf HC
    Br J Dermatol; 2017 May; 176(5):1241-1246. PubMed ID: 27696393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protoporphyrin IX formation after application of methyl aminolevulinate on the face and scalp with and without prior curettage.
    Heerfordt IM; Bieliauskiene G; Wulf HC
    Photodiagnosis Photodyn Ther; 2018 Jun; 22():155-157. PubMed ID: 29601904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis.
    Torezan L; Grinblat B; Haedersdal M; Valente N; Festa-Neto C; Szeimies RM
    Br J Dermatol; 2018 Oct; 179(4):829-835. PubMed ID: 29476546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial.
    Togsverd-Bo K; Haak CS; Thaysen-Petersen D; Wulf HC; Anderson RR; Hædersdal M
    Br J Dermatol; 2012 Jun; 166(6):1262-9. PubMed ID: 22348388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
    Tyrrell JS; Morton C; Campbell SM; Curnow A
    Br J Dermatol; 2011 Jun; 164(6):1362-8. PubMed ID: 21564050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial.
    Wiegell SR; Petersen B; Wulf HC
    Br J Dermatol; 2014 Dec; 171(6):1487-92. PubMed ID: 25060803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daylight photodynamic therapy of actinic keratosis without curettage is as effective as with curettage: a randomized clinical trial.
    Heerfordt IM; Wulf HC
    J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):2058-2061. PubMed ID: 31197894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial.
    Togsverd-Bo K; Halldin C; Sandberg C; Gonzalez H; Wennberg AM; Sørensen SS; Wulf HC; Haedersdal M
    Br J Dermatol; 2018 Apr; 178(4):903-909. PubMed ID: 28796885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulse photodynamic therapy reduces inflammation without compromising efficacy in the treatment of multiple mild actinic keratoses of the face and scalp: a randomized clinical trial.
    Wiegell SR; Petersen B; Wulf HC
    Br J Dermatol; 2016 May; 174(5):979-84. PubMed ID: 26852899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
    Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
    Gutiérrez García-Rodrigo C; Pellegrini C; Piccioni A; Tambone S; Fargnoli MC
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():100-104. PubMed ID: 31141730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy.
    Kanick SC; Davis SC; Zhao Y; Sheehan KL; Hasan T; Maytin EV; Pogue BW; Chapman MS
    Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):561-6. PubMed ID: 26480810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New aspects in photodynamic therapy of actinic keratoses.
    Smits T; Moor AC
    J Photochem Photobiol B; 2009 Sep; 96(3):159-69. PubMed ID: 19592269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
    Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy using intense pulsed light for treating actinic keratoses and photoaged skin of the dorsal hands: a randomized placebo-controlled study.
    Kohl E; Popp C; Zeman F; Unger P; Koller M; Landthaler M; Karrer S; Szeimies RM
    Br J Dermatol; 2017 Feb; 176(2):352-362. PubMed ID: 27518833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
    Tyrrell JS; Campbell SM; Curnow A
    Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial.
    O'Gorman SM; Clowry J; Manley M; McCavana J; Gray L; Kavanagh A; Lally A; Collins P
    JAMA Dermatol; 2016 Jun; 152(6):638-44. PubMed ID: 26843523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study.
    Wiegell SR; Haedersdal M; Philipsen PA; Eriksen P; Enk CD; Wulf HC
    Br J Dermatol; 2008 Apr; 158(4):740-6. PubMed ID: 18294318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.
    Lacour JP; Ulrich C; Gilaberte Y; Von Felbert V; Basset-Seguin N; Dreno B; Girard C; Redondo P; Serra-Guillen C; Synnerstad I; Tarstedt M; Tsianakas A; Venema AW; Kelleners-Smeets N; Adamski H; Perez-Garcia B; Gerritsen MJ; Leclerc S; Kerrouche N; Szeimies RM
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2342-8. PubMed ID: 26435363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
    Neittaanmäki-Perttu N; Karppinen TT; Grönroos M; Tani TT; Snellman E
    Br J Dermatol; 2014 Nov; 171(5):1172-80. PubMed ID: 25109244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.